News Oxford BioMedica could get $100m following CAR-T approval UK biotech will supply key component of Novartis' newly approved cancer cell therapy
News Oxford BioMedica signs $100m CAR-T deal with Novartis UK firm to supply viruses to generate CAR-T therapies
News NHS staff 'feel unprepared for digital transformation' A survey of NHS workers has found that almost two-thirds feel they are unprepared for the digital transformation objectives of the 10-Year Plan.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
